Article ; Online: The use of buprenorphine to-go packs in the emergency department.
The American journal of emergency medicine
2023 Volume 77, Page(s) 154–157
Abstract: Objective: Buprenorphine is an effective treatment for opioid use disorder (OUD). Patients in the emergency department (ED) can be initiated or continued on buprenorphine as a bridge to follow-up in the outpatient setting, but gaps in care may arise. ... ...
| Abstract | Objective: Buprenorphine is an effective treatment for opioid use disorder (OUD). Patients in the emergency department (ED) can be initiated or continued on buprenorphine as a bridge to follow-up in the outpatient setting, but gaps in care may arise. The objective was to evaluate the impact of buprenorphine to-go packs as a continuing treatment option for patients presenting to the ED with OUD across a health system. Methods: Adult patients discharged with a buprenorphine to-go pack from one of ten EDs within a major health system were included. The primary outcomes assessed within 30 days of ED discharge were: (1) return to a health system ED, and (2) fill history of buprenorphine in the state prescription drug monitoring program database. Data was analyzed using descriptive statistics in Microsoft Excel (Redmond, WA). Results: A total of 124 patients received buprenorphine to-go packs. The sample was primarily male (79; 63.7%), white (89; 71.8%), on Medicaid (79; 63.7%), and had a mean age of 40.9 years. A total of 43 patients (34.7%) were initiated on buprenorphine for the first time, while 81 (65.3%) had received buprenorphine (prescription or to-go) previously. At 30 days post-visit, 76 (61.3%) had filled buprenorphine prescriptions, and 40 (32.3%) returned to an ED within the health system for opioid withdrawal (17; 42.5%), non-OUD-related reasons (22; 55%), or overdose (1; 2.5%). Conclusion: The implementation of a system-wide buprenorphine to-go supply at ED discharge is a feasible option to provide continuity of care to patients with OUD. |
|---|---|
| MeSH term(s) | Adult ; United States ; Humans ; Male ; Buprenorphine/therapeutic use ; Narcotic Antagonists/therapeutic use ; Opiate Substitution Treatment ; Emergency Service, Hospital ; Opioid-Related Disorders/drug therapy |
| Chemical Substances | Buprenorphine (40D3SCR4GZ) ; Narcotic Antagonists |
| Language | English |
| Publishing date | 2023-12-20 |
| Publishing country | United States |
| Document type | Journal Article |
| ZDB-ID | 605890-5 |
| ISSN | 1532-8171 ; 0735-6757 |
| ISSN (online) | 1532-8171 |
| ISSN | 0735-6757 |
| DOI | 10.1016/j.ajem.2023.12.025 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2005: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.